Browsing by Author "Connock, Martin"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? : A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis(2022-12-13) Armoiry, Xavier; Wang-Steverding, Xia; Connock, Martin; Grove, Amy; Clarke, Aileen; Arun, Tarunya; Counsell, Carl; Auguste, Peter; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health SciencesItem Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England : a review comparing the assessment by HAS and NICE(2021-06-03) Armoiry, Xavier; Späth, Hans-Martin; Henaine , Anna-Maria; Dussart, Claude; Counsell, Carl; Connock, Martin; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health Sciences